Log in

Krishna Institute of Medical Sciences

NSE: KIMS · ISIN INE967H01025 · Healthcare

₹725.55−9.15 (−1.25%)

Monday 9 November, 12:18 IST. Delayed. Source: Yahoo Finance.

Price chart

₹725.55 −9.15 (−1.25%) today

The day

Previous close
₹734.70
Open
₹734.00
Day high
₹735.45
Day low
₹721.80

Listed on NSE since 28 June 2021.

Key numbers

Market value
₹30,366 Cr
P/E (trailing)
138.51
EPS (trailing)
₹5.22
Price to book
12.87
Dividend yield
0.00%
Debt to equity
1.66
Profit margin
4.8%
Beta
0.33
Volume today
90,910
Average volume
5.17 L

Source: Yahoo Finance. Ratios use the latest reported (trailing twelve-month) figures.

Revenue and profit

Annual revenue and profit
YearRevenueNet profitEPS
FY23₹2,167.66 Cr₹336.32 Cr₹8.41
FY24₹2,474.00 Cr₹310.00 Cr₹7.75
FY25₹3,003.50 Cr₹384.50 Cr₹9.61
FY26₹3,872.10 Cr₹241.40 Cr₹6.03

Source: Yahoo Finance, from annual reports. Consolidated where reported.

Quarterly results

Results for each quarter, latest first
QuarterRevenueNet profitEPSProfit vs year ago
Q2 FY27Jul–Sep 2026₹1,344 Cr₹75 Cr₹1.79+11.8%
Q1 FY27Apr–Jun 2026₹1,180 Cr₹42 Cr₹1.04−47.2%
Q4 FY26Jan–Mar 2026Audited₹1,075 Cr₹43 Cr₹1.06−58.3%
Q3 FY26Oct–Dec 2025₹998 Cr₹53 Cr₹1.33–
Q2 FY26Jul–Sep 2025₹961 Cr₹67 Cr₹1.67–
Q1 FY26Apr–Jun 2025₹872 Cr₹79 Cr₹1.96–

Source: Krishna Institute of Medical Sciences’s results filed with NSE, consolidated (the whole group). Net profit is the share of Krishna Institute of Medical Sciences’s own shareholders where the filing separates it. Profit vs year ago compares with the same quarter a year earlier; – where that quarter is not on file or made a loss.

Download results (zip) A spreadsheet of the quarterly results and balance sheets, with the original filings from NSE.

Balance sheet

What the company owns and owes, latest first
As onSeptember 2026March 2026September 2025
Fixed assets₹5,316 Cr₹4,792 Cr₹4,075 Cr
Investments₹413 Cr₹16 Cr₹98 Cr
Inventories₹119 Cr₹97 Cr₹80 Cr
Owed by customers₹691 Cr₹554 Cr₹484 Cr
Cash and equivalents₹53 Cr₹55 Cr₹81 Cr
Total assets₹8,912 Cr₹7,759 Cr₹6,625 Cr
Borrowings₹3,538 Cr₹3,244 Cr₹3,187 Cr
Total liabilities₹4,660 Cr₹5,200 Cr₹4,049 Cr
Shareholders’ equity₹3,932 Cr₹2,247 Cr₹2,270 Cr

Source: Krishna Institute of Medical Sciences’s half-yearly statements of assets and liabilities filed with NSE, consolidated. Companies file these every September and March.

About Krishna Institute of Medical Sciences

Krishna Institute of Medical Sciences Limited provides medical and health care services under the KIMS Hospitals brand in India. The company offers arthroscopy and shoulder, cardiology, cardiothoracic and cardiovascular, organ transplant, medical and surgical gastroenterology, hepatology, orthopaedic, neurology, neurosurgery, nephrology, urology, oncology, pediatric, neonatology, obstetrics and gynaecology, fertility, dental science, emergency and critical care, vascular, rehabilitation and physiotherapy services. It also provides pulmonology, diagnostic and imaging, ophthalmology, ENT, rheumatology and clinical immunology, internal medicine, interventional radiology, diabetology, endocrinology, general surgery, infectious disease, dermatology, thoracic surgery, psychiatry, plastic and reconstructive surgery, transfusion medicine, clinical psychology, anesthesiology, and tele medicine services. In addition, the company operates clinical immunology allergy, bone marrow transplantation, hair transplant, andrology, fertility, alzheimer, arthroscopy, bone and joint, breast, dialysis, female urology, IUI, IVF, joint replacement, kidney health and transplant, ICU, spine, stroke, TAVR/TAVI, hepatobiliary surgery, and trauma centers, as well as pain and wellness clinics. Further, it provides bariatric, thoracic, oral maxillofacial, and endovascular surgery services. Krishna Institute of Medical Sciences Limited was incorporated in 1973 and is based in Secunderabad, India.

Industry
Medical Care Facilities
Based in
Secunderabad

Company website · Profile: Yahoo Finance

In the news

All news

No headlines name Krishna Institute of Medical Sciences in the last day or two.

Dividends and corporate actions

All companies
  • Face Value Split (Sub-Division) - From Rs 10/- Per Share To Rs 2/- Per Share

    Split · ex-date 13 September 2024

Source: NSE. Latest first.

Information only, not investment advice. Prices are delayed.

ShareWhatsAppTelegram

Open inZerodha ↗Groww ↗Angel One ↗For convenience only: no referral, not a recommendation.